Associations of serum soluble klotho and fibroblast growth factor 23 with carotid artery calcification in patients undergoing continuous ambulatory peritoneal dialysis: A retrospective study.

Naifeng Guo, Xu Chen, Yingjie Cao, Guoyuan Lu
Author Information
  1. Naifeng Guo: Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  2. Xu Chen: Department of Nephrology, The Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  3. Yingjie Cao: Department of Nephrology, The Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  4. Guoyuan Lu: Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, China. ORCID

Abstract

ABSTRACT: This study aimed to assess the associations of serum soluble klotho and fibroblast growth factor 23 (FGF-23) with the occurrence of carotid artery calcification. Peritoneal dialysis patients treated from June 2018 to June 2019 were retrospectively analyzed. They were divided into the carotid artery calcification and non-carotid artery calcification groups according to color Doppler ultrasound findings. Basic indicators in both groups were compared, and the influencing factors of carotid artery calcification were analyzed by logistic regression. Among the 73 continuous ambulatory peritoneal dialysis (CAPD) patients enrolled, 40 (54.8%) had carotid artery calcification. Significant differences were found in age (68.85 ± 7.45 vs 46.62 ± 5.51 years), dialysis time (8.15 ± 1.42 vs 6.02 ± 1.14 months), klotho amounts (325.56 ± 41.15 vs 436.65 ± 45.58 pg/mL) and FGF-23 levels (114.45 ± 15.56 vs 70.15 ± 12.23 pg/mL) between the carotid artery calcification and non-carotid artery calcification groups (all P < .001). The above factors were associated with carotid artery calcification occurrence in univariate analysis. Multivariate analysis showed that elevated age (odds ratio [OR] = 1.55, 95% confidence interval [CI] 1.13-1.74; P = .025) and FGF-23 (OR = 2.16, 95% CI 2.01-2.44; P = .042), and lower klotho (OR = 0.66, 95% CI 0.47-0.85; P = .036) were independent risk factors for carotid artery calcification in CAPD. Serum FGF-23 and age are risk factors for carotid artery calcification in patients with CAPD, whereas klotho is a protective factor.

References

  1. Atherosclerosis. 2018 Nov;278:49-59 [PMID: 30253289]
  2. BMC Neurol. 2019 Jul 29;19(1):178 [PMID: 31357950]
  3. Sci Rep. 2019 Jul 16;9(1):10266 [PMID: 31312004]
  4. BMJ Open. 2020 Mar 23;10(3):e032849 [PMID: 32205371]
  5. JACC Basic Transl Sci. 2020 Apr 27;5(4):398-412 [PMID: 32368697]
  6. Toxins (Basel). 2019 Mar 22;11(3): [PMID: 30909513]
  7. J Am Soc Nephrol. 2011 Jan;22(1):124-36 [PMID: 21115613]
  8. Contrib Nephrol. 2019;198:62-72 [PMID: 30991406]
  9. Bone. 2017 Jul;100:87-93 [PMID: 27847254]
  10. Nat Rev Nephrol. 2011 Aug 23;7(10):567-77 [PMID: 21862991]
  11. Sheng Li Xue Bao. 2018 Dec 25;70(6):639-643 [PMID: 30560273]
  12. Lancet Diabetes Endocrinol. 2014 May;2(5):427-36 [PMID: 24795256]
  13. Saudi J Kidney Dis Transpl. 2014 Jul;25(4):788-92 [PMID: 24969189]
  14. Kidney Int Suppl (2011). 2020 Mar;10(1):e24-e48 [PMID: 32149007]
  15. Front Endocrinol (Lausanne). 2018 May 02;9:189 [PMID: 29770125]
  16. Contrib Nephrol. 2015;185:156-67 [PMID: 26023025]
  17. Curr Vasc Pharmacol. 2018 Jan 26;16(2):143-156 [PMID: 28294047]
  18. Clin Exp Nephrol. 2017 Mar;21(Suppl 1):64-69 [PMID: 27838783]
  19. J Nephrol. 2019 Apr;32(2):307-314 [PMID: 30465136]
  20. Clin J Am Soc Nephrol. 2016 Jun 6;11(6):956-963 [PMID: 27173168]
  21. Kidney Dis (Basel). 2017 Jul;3(1):15-23 [PMID: 28785560]
  22. Front Med (Lausanne). 2018 Jul 24;5:206 [PMID: 30087898]
  23. Pragmat Obs Res. 2016 Aug 17;7:21-32 [PMID: 27822135]

Grants

  1. JCZ19045/Nantong Municipal Science and Technology Plan (Guiding) Project

MeSH Term

Aged
Calcification, Physiologic
Carotid Artery Diseases
China
Fibroblast Growth Factor-23
Fibroblast Growth Factors
Glucuronidase
Humans
Klotho Proteins
Male
Middle Aged
Odds Ratio
Peritoneal Dialysis, Continuous Ambulatory
Retrospective Studies
Risk Factors

Chemicals

FGF23 protein, human
Fibroblast Growth Factors
Fibroblast Growth Factor-23
Glucuronidase
Klotho Proteins

Word Cloud

Created with Highcharts 10.0.0arterycalcificationcarotidklothoFGF-23patientsfactorsvsfactordialysisgroupsCAPDage95%P = studyserumsolublefibroblastgrowth23occurrenceJuneanalyzednon-carotidcontinuousambulatoryperitonealanalysisCIriskABSTRACT:aimedassessassociationsPeritonealtreated20182019retrospectivelydividedaccordingcolorDopplerultrasoundfindingsBasicindicatorscomparedinfluencinglogisticregressionAmong73enrolled40548%Significantdifferencesfound6885 ± 7454662 ± 551 yearstime815 ± 142602 ± 114 monthsamounts32556 ± 411543665 ± 4558 pg/mLlevels11445 ± 15567015 ± 1223 pg/mLP <001associatedunivariateMultivariateshowedelevatedoddsratio[OR] = 155confidenceinterval[CI]113-174025OR = 216201-244042lowerOR = 066047-085036independentSerumwhereasprotectiveAssociationsundergoingdialysis:retrospective

Similar Articles

Cited By